Prospectus

Pearl Diver Credit Company Inc. Announces Closing of Initial Public Offering and Full Exercise of Overallotment Option

Retrieved on: 
Friday, July 19, 2024

NEW YORK and LONDON, July 19, 2024 /PRNewswire/ -- Pearl Diver Credit Company Inc. (NYSE: PDCC) (the "Company") today announced the closing of its previously announced initial public offering of 2.2 million shares of common stock at a public offering price of $20.00 per share and the full exercise of the overallotment option of 330,000 shares for total net proceeds to the Company of $50.6 million.

Key Points: 
  • NEW YORK and LONDON, July 19, 2024 /PRNewswire/ -- Pearl Diver Credit Company Inc. (NYSE: PDCC) (the "Company") today announced the closing of its previously announced initial public offering of 2.2 million shares of common stock at a public offering price of $20.00 per share and the full exercise of the overallotment option of 330,000 shares for total net proceeds to the Company of $50.6 million.
  • Pearl Diver Capital LLP ("Pearl Diver Capital"), the Company's investment adviser, or its affiliates will pay the full amount of the sales load in connection with this initial public offering and all of the Company's organizational and offering expenses.
  • Shares of the Company's common stock began trading on the New York Stock Exchange under the symbol "PDCC" on July 18, 2024.
  • As of the close of trading on July 19, 2024, the Company's market capitalization was approximately $136 million.

POET Technologies Announces US$10 Million Registered Direct Offering

Retrieved on: 
Friday, July 19, 2024

The combined price of one Common Share and accompanying Warrant in respect of one Common Share was US$3.00 (or approximately C$4.09).

Key Points: 
  • The combined price of one Common Share and accompanying Warrant in respect of one Common Share was US$3.00 (or approximately C$4.09).
  • The Corporation intends to use the net proceeds of the Offering for working capital and general corporate purposes.
  • No commission or finder's fee was paid by the Corporation and no underwriter or sales agent was engaged by the Corporation in connection with the Offering.
  • This Offering is being made pursuant to an effective shelf registration statement on Form F-3 (File No.

Lifeist Announces Closing of Non-Brokered Debt Financing

Retrieved on: 
Friday, July 19, 2024

TORONTO, July 19, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF) a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, today announced that it has closed a non-brokered private placement (the "Offering") of secured convertible debentures (the "Debentures") for aggregate gross proceeds to the Company of $450,000 (“Principal Amount”). The Company intends to use the proceeds from the Offering to pay existing accounts payable and for business development and general corporate purposes.

Key Points: 
  • The Company intends to use the proceeds from the Offering to pay existing accounts payable and for business development and general corporate purposes.
  • The Debentures will bear interest at a rate of 10% per annum, and mature on July 19, 2025 (the “Maturity Date”).
  • Completion of the Offering is subject to certain conditions including, but not limited to, the receipt of all necessary approvals.
  • Closing of the Offering is subject to regulatory approval, including that of the TSX Venture Exchange ("TSXV").

Ardent Health Announces Closing of Its Initial Public Offering

Retrieved on: 
Friday, July 19, 2024

Ardent Health Partners, Inc. (NYSE: ARDT) (f/k/a Ardent Health Partners, LLC and collectively “Ardent Health” or the “Company”), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced the closing of its initial public offering (the “Offering”) of 12,000,000 shares of its common stock sold by the Company at a public offering price of $16 per share, for total gross proceeds of approximately $192 million, before deducting underwriting discounts, commissions and other offering expenses.

Key Points: 
  • Ardent Health Partners, Inc. (NYSE: ARDT) (f/k/a Ardent Health Partners, LLC and collectively “Ardent Health” or the “Company”), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced the closing of its initial public offering (the “Offering”) of 12,000,000 shares of its common stock sold by the Company at a public offering price of $16 per share, for total gross proceeds of approximately $192 million, before deducting underwriting discounts, commissions and other offering expenses.
  • In addition, the Company has granted the underwriters a 30-day option to purchase an additional 1,800,000 shares at the public offering price, less underwriting discounts and commissions.
  • View the full release here: https://www.businesswire.com/news/home/20240719421754/en/
    Ardent Health President & Chief Executive Officer Marty Bonick and other Ardent Health executives and board members ring the opening bell at the New York Stock Exchange on Thursday, July 18, 2024.
  • A prospectus relating to and describing the terms of the offering has been filed with the SEC and is available on the SEC's website at www.sec.gov .

RiverNorth Opportunities Fund, Inc., RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. and RiverNorth Capital and Income Fund, Inc. Announce Preferred Dividends

Retrieved on: 
Friday, July 19, 2024

RiverNorth Capital and Income Fund, Inc.

Key Points: 
  • RiverNorth Capital and Income Fund, Inc.
    RiverNorth Capital Management, LLC is an investment management firm founded in 2000.
  • RiverNorth is an institutional investment manager to registered funds, private funds and separately managed accounts.
  • Distributions may be paid from sources of income other than ordinary income, such as net realized short-term capital gains, net realized long-term capital gains and return of capital.
  • RiverNorth is not a tax advisor and investors should consult a tax professional for guidance regarding their specific tax situation.

EQS-News: TUI repurchases € 472m convertible bonds due 2028

Retrieved on: 
Friday, July 19, 2024

TUI has decided to repurchase € 472 million of the 2028 Bonds (the “Final Acceptance Amount”), representing approximately 80% of the outstanding principal amount.

Key Points: 
  • TUI has decided to repurchase € 472 million of the 2028 Bonds (the “Final Acceptance Amount”), representing approximately 80% of the outstanding principal amount.
  • To fund these repurchases, TUI will use proceeds from the successful offering of € 487 million convertible bonds due 2031, announced yesterday.
  • The Purchase Price is 101.5% of the Principal Amount per 2028 Bond offered in the Convertible Bonds Tender Offer (equal to € 101,500 per € 100,000 in Principal Amount of the 2028 Bonds).
  • Following the repurchase, 2028 Bonds in an aggregate principal amount of € 117.6 million will remain outstanding.

HYZON ANNOUNCES PRICING OF $4.5 MILLION REGISTERED DIRECT OFFERING

Retrieved on: 
Friday, July 19, 2024

The closing of the offering is expected to occur on or about July 22, 2024.

Key Points: 
  • The closing of the offering is expected to occur on or about July 22, 2024.
  • The Company intends to use the net proceeds from this offering primarily for funding working capital and other general corporate purposes.
  • Roth Capital Partners is acting as exclusive placement agent for the offering on a best efforts basis.
  • The gross proceeds from the offering to the Company are expected to be approximately $4.5 million, before deducting placement agent fees and other offering expenses payable by the Company.

Announces Pricing of $5.0 Million Registered Direct Offering and Concurrent Private Placement

Retrieved on: 
Friday, July 19, 2024

The gross proceeds from the offering are expected to be approximately $5.0 million, before deducting placement agent fees and other estimated offering expenses.

Key Points: 
  • The gross proceeds from the offering are expected to be approximately $5.0 million, before deducting placement agent fees and other estimated offering expenses.
  • The offering is expected to close on or about July 22, 2024, subject to the satisfaction of customary closing conditions.
  • Ladenburg Thalmann & Co. Inc. acted as sole placement agent in connection with the offering.
  • Any offering of the securities under the resale registration statement will only be made by means of a prospectus.

Plug Power Inc. Announces Pricing of Public Offering of Common Stock

Retrieved on: 
Friday, July 19, 2024

LATHAM, N.Y., July 19, 2024 (GLOBE NEWSWIRE) -- Plug Power Inc. (“Plug Power”) (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the green hydrogen economy, today announced the pricing of its previously announced underwritten public offering of 78,740,157 shares of its common stock at a price to the public of $2.54 per share.

Key Points: 
  • LATHAM, N.Y., July 19, 2024 (GLOBE NEWSWIRE) -- Plug Power Inc. (“Plug Power”) (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the green hydrogen economy, today announced the pricing of its previously announced underwritten public offering of 78,740,157 shares of its common stock at a price to the public of $2.54 per share.
  • In connection with the offering, Plug Power has granted the underwriters a 30-day option to purchase up to an additional 11,811,023 shares of common stock at the public offering price, less the underwriting discount.
  • The gross proceeds to Plug Power from the offering, before deducting the underwriting discount and other offering expenses payable by Plug Power, are expected to be approximately $200 million.
  • Plug Power intends to use the net proceeds from the offering for general corporate purposes.

Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Retrieved on: 
Friday, July 19, 2024

The closing of the offering is expected to occur on or about July 22, 2024, subject to the satisfaction of customary closing conditions.

Key Points: 
  • The closing of the offering is expected to occur on or about July 22, 2024, subject to the satisfaction of customary closing conditions.
  • The gross proceeds to the Company from the offering are expected to be approximately $2.1 million before deducting placement agent fees and other offering expenses payable by the Company.
  • The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.
  • A final prospectus supplement and accompanying prospectus relating to the registered direct offering will be filed with the SEC.